Frontiers in Microbiology (Nov 2022)
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections
- Yun Shan Goh,
- Siew-Wai Fong,
- Pei Xiang Hor,
- Siti Naqiah Amrun,
- Cheryl Yi-Pin Lee,
- Barnaby Edward Young,
- Barnaby Edward Young,
- Barnaby Edward Young,
- Po Ying Chia,
- Po Ying Chia,
- Po Ying Chia,
- Paul A. Tambyah,
- Paul A. Tambyah,
- Shirin Kalimuddin,
- Shirin Kalimuddin,
- Surinder Pada,
- Seow-Yen Tan,
- Louisa Jin Sun,
- Mark I-Cheng Chen,
- Mark I-Cheng Chen,
- Yee-Sin Leo,
- Yee-Sin Leo,
- Yee-Sin Leo,
- Yee-Sin Leo,
- Yee-Sin Leo,
- Yee-Sin Leo,
- David C. Lye,
- David C. Lye,
- David C. Lye,
- David C. Lye,
- Lisa F. P. Ng,
- Lisa F. P. Ng,
- Lisa F. P. Ng,
- Laurent Renia,
- Laurent Renia,
- Laurent Renia
Affiliations
- Yun Shan Goh
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Siew-Wai Fong
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Pei Xiang Hor
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Siti Naqiah Amrun
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Cheryl Yi-Pin Lee
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Barnaby Edward Young
- National Centre for Infectious Diseases, Singapore, Singapore
- Barnaby Edward Young
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore
- Barnaby Edward Young
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- Po Ying Chia
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore
- Po Ying Chia
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- Po Ying Chia
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Paul A. Tambyah
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore
- Paul A. Tambyah
- Department of Infectious Diseases, National University Health System, Singapore, Singapore
- Shirin Kalimuddin
- Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore
- Shirin Kalimuddin
- Emerging Infectious Disease Program, Duke-NUS Medical School, Singapore, Singapore
- Surinder Pada
- Division of Infectious Diseases, Ng Teng Fong Hospital, Singapore, Singapore
- Seow-Yen Tan
- 0Department of Infectious Diseases, Changi General Hospital, Singapore, Singapore
- Louisa Jin Sun
- 1Alexandra Hospital, Singapore, Singapore
- Mark I-Cheng Chen
- National Centre for Infectious Diseases, Singapore, Singapore
- Mark I-Cheng Chen
- 2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
- Yee-Sin Leo
- National Centre for Infectious Diseases, Singapore, Singapore
- Yee-Sin Leo
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore
- Yee-Sin Leo
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- Yee-Sin Leo
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Yee-Sin Leo
- 2Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
- Yee-Sin Leo
- 3Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore, Singapore
- David C. Lye
- National Centre for Infectious Diseases, Singapore, Singapore
- David C. Lye
- Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore
- David C. Lye
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- David C. Lye
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Lisa F. P. Ng
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Lisa F. P. Ng
- 4National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, United Kingdom
- Lisa F. P. Ng
- 5Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom
- Laurent Renia
- A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
- Laurent Renia
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
- Laurent Renia
- 6School of Biological Sciences, Nanyang Technological University, Singapore, Singapore
- DOI
- https://doi.org/10.3389/fmicb.2022.1043049
- Journal volume & issue
-
Vol. 13
Abstract
IntroductionCOVID-19 has a wide disease spectrum ranging from asymptomatic to severe. While humoral immune responses are critical in preventing infection, the immune mechanisms leading to severe disease, and the identification of biomarkers of disease progression and/or resolution of the infection remains to be determined.MethodsPlasma samples were obtained from infections during the initial wave of ancestral wildtype SARS-CoV-2 and from vaccine breakthrough infections during the wave of Delta variant, up to six months post infection. The spike-specific antibody profiles were compared across different severity groups and timepoints.ResultsWe found an association between spike-specific IgM, IgA and IgG and disease severity in unvaccinated infected individuals. In addition to strong IgG1 and IgG3 response, patients with severe disease develop a robust IgG2 and IgG4 response. A comparison of the ratio of IgG1 and IgG3 to IgG2 and IgG4 showed that disease progression is associated with a smaller ratio in both the initial wave of WT and the vaccine breakthrough Delta infections. Time-course analysis revealed that smaller (IgG1 and IgG3)/(IgG2 and IgG4) ratio is associated with disease progression, while the reverse associates with clinical recovery.DiscussionWhile each IgG subclass is associated with disease severity, the balance within the four IgG subclasses may affect disease outcome. Acute disease progression or infection resolution is associated with a specific immunological phenotype that is conserved in both the initial wave of WT and the vaccine breakthrough Delta infections.
Keywords